Dr. Ann de Wees Allen® is the leading clinical and medical researcher in the field of algorithmic mechanisms in binary neural networks. Her life’s work has been to drive cutting edge research in Glycemic Index Claims development and clinical trials, metabolic intelligence, brain glycemic indexing, neural nutrition, neural coding, beverage technology, lipoprotein lipase(LPL), thermogenesis, obesity, childhood obesity, Key Codes to Adipose Tissue Fat Cell Metabolism, Sickle Cell Disease (Presented at the United Nations General Assembly, New York) Metabolic Medicine, growth hormone, anti aging, L-arginine, human sports performance and neural food addictions. ‍ Dr. Allen’s expertise in the gut-brain axis and discoveries in breaking the blood brain barrier is unmatched in the food and beverage industry. Her proficiency in nutritional neuro-navigational science ranges from managing fat cells to enhancing concentration in gamers to boosting nitric oxide for elite mountain climbers. All of her methodologies are grounded in clinical research, making her an authority in her field and which reflected in trademarks and patents such as Switch the Brain-Switch the Game® - the bio-technology that transforms average beverages into functional performance beverages. ‍ A few of her most notable accomplishments are recorded when she was awarded the first glycemic patent and then recognized as the Breakthrough Product of the Year by Success Magazine; she was recognized to have generated $300 million in sales within the first year from her patented technology being awarded. And her patents & bio-technology has generated over $1 billion dollars in revenue globally. Dr. Ann de Wees Allen® is considered one of the most revered and successful scientists in the world.